FIELD: organic chemistry, medicine, pharmacy.
SUBSTANCE: invention describes a novel derivative of 5-methoxy-8-aryl[1,2,4]-triazole[1,5-a]pyridine of the general formula (I): 
wherein R1 means hydrogen, halogen atom or lower alkoxy-group; R2 means -C(O)-phenyl wherein ring can be unsubstituted or substituted with one or two substitutes chosen from group consisting of halogen atom, lower alkyl, lower alkoxy-group or trifluoromethyl, or it means -C(O)-furanyl or -C(O)-thiophenyl wherein rings are not substituted or substituted with halogen atom, and its pharmaceutically acceptable salts. Proposed compounds can be used in treatment of diseases associated with adenosine A2 receptors. Also, invention describes a medicinal agent used in treatment of diseases associated with adenosine A2A receptors containing compound of the formula (I) and pharmaceutically acceptable excipients.
EFFECT: valuable medicinal properties of agent.
8 cl, 1 tbl, 1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| DERIVATIVES OF 8-METHOXY-[1,2,4]TRIAZOLO[1,5-a]PYRIDINE AND PHARMACEUTICAL PREPARATION BASED ON THEREOF | 2002 |
|
RU2297416C2 |
| 8-AMINO-[1,2,4]TRIAZOLO-[1,5-A]PYRIDINE-6-CARBOXYLIC ACID AMIDE AND MEDICINAL AGENT COMPRISING THEREOF | 2002 |
|
RU2296763C2 |
| DERIVATIVES OF 1,2,4-TRIAZINE-4-AMINE | 2011 |
|
RU2625791C2 |
| SUBSTITUTED [1,2,4]TRIAZOLO[4,3-a]PYRIDINES, DEMONSTRATING PROPERTIES OF ANTAGONISTS OF ADENOSINE A2A RECEPTORS, AND THEIR APPLICATION | 2013 |
|
RU2534804C1 |
| 1,2,4-TRIAZOLONE DERIVATIVE | 2011 |
|
RU2566754C2 |
| 1,2,4-TRIAZINE-3-AMINE DERIVATIVES | 2011 |
|
RU2771819C2 |
| N-(PYRID-4-YL) AMIDES AND N-(PYRIMIDIN-4-YL) AMIDES AND THEIR PHARMACEUTICAL AND COSMETIC APPLICATION | 2012 |
|
RU2625789C2 |
| BENZIMIDAZOLE DERIVATIVES AS ADENOSINE RECEPTOR ANTAGONISTS | 2018 |
|
RU2781429C2 |
| AZOLE DERIVATIVES | 2012 |
|
RU2622639C2 |
| QUINOXALINE DERIVATIVES AS ADENOSINE RECEPTOR ANTAGONISTS | 2018 |
|
RU2791168C1 |
